Midwest Cancer Center - Legacy — Omaha, Nebraska

Midwest Cancer Center - Legacy is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Midwest Cancer Center - Legacy has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma, Metastatic Melanoma.

Sponsors: Prometheus Laboratories.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Midwest Cancer Center - Legacy?

Midwest Cancer Center - Legacy has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Midwest Cancer Center - Legacy conducted?

Midwest Cancer Center - Legacy has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma, Metastatic Melanoma.

Is Midwest Cancer Center - Legacy accredited by Crixeo Health?

Midwest Cancer Center - Legacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Midwest Cancer Center - Legacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.